Overall body weight and BMI did not change significantly, but small improvements were noticed in men
Crandall says, "If someone lost 50 pounds, it would be impossible for them to not also lose lean body mass, so we'll help them mitigate that loss, whether its through aerobic or anaerobic conditioning or strength training." The most important aspect of the program he says, is knowing that most people on GLP1 drugs don't want to be on them forever
Technology, expertise, and partnership work in harmony enabling the agility, reliability, and foresight that todays GLP-1 market demands
Is pulsatile meaningfully better than sustained at wellness doses
Pricing comparison (monthly cost, April 2026): Key differences: Compounded semaglutide is the same active molecule (semaglutide) but prepared by a state-licensed compounding pharmacy rather than manufactured by Novo Nordisk It is not FDA-approved and has not undergone the same safety and efficacy review as Wegovy It requires drawing the dose from a vial with a U-100 insulin syringe rather than using a pre-filled pen It is typically dosed weekly at equivalent doses to Wegovy (0.25 mg through 2.4 mg titration schedule) When compounded makes financial sense: Your insurance does not cover Wegovy, and you are paying full cash price Your copay exceeds $200 per month and you do not qualify for the savings card You are on Medicare or Medicaid (ineligible for WegovySavings card) You want predictable monthly pricing without insurance paperwork or prior authorization delays When brand Wegovy makes more sense: Your copay is $25 or less with the savings card You qualify for the patient assistance program and can get Wegovy free You strongly prefer FDA-approved medications You want the convenience of a pre-filled pen and are willing to pay for it You have difficulty with manual injections or visual impairment that makes pen injectors safer The decision is patient-specific and should involve a licensed provider
